On Aug. 13, the FDA posted new and revised versions of the following Import Alerts (after not having posted new ones for a number of days) on the detention without physical examination of:

On Aug. 9, the FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of:

On Aug. 8, the FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of:

On Aug. 5, the FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of:

On Aug. 2, the FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of:

On Aug. 1, the FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of:

On July 31, the FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of:

On July 30, the FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of:

On July 29, the FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of:

The FDA set potential FY 2025 fees for import reinspections, domestic and foreign facility reinspections, and recall activities the agency performs if a firm fails to comply with a mandatory recall order, though it still isn't invoicing for services associated with the fees, it said in a notice. The agency set FY 2025 fees of $340 per hour for domestic services involving travel and $373 hourly if foreign travel is required.